1. Home
  2. DLNG vs NTHI Comparison

DLNG vs NTHI Comparison

Compare DLNG & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynagas LNG Partners LP

DLNG

Dynagas LNG Partners LP

HOLD

Current Price

$3.80

Market Cap

140.8M

ML Signal

HOLD

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$4.61

Market Cap

121.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLNG
NTHI
Founded
2013
2008
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.8M
121.3M
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
DLNG
NTHI
Price
$3.80
$4.61
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
48.9K
244.6K
Earning Date
05-26-2026
05-19-2026
Dividend Yield
5.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.10
N/A
P/E Ratio
$3.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.27
$3.01
52 Week High
$4.45
$12.99

Technical Indicators

Market Signals
Indicator
DLNG
NTHI
Relative Strength Index (RSI) 51.01 56.56
Support Level $3.28 $4.18
Resistance Level $3.81 $5.79
Average True Range (ATR) 0.13 0.73
MACD -0.01 0.07
Stochastic Oscillator 29.17 57.25

Price Performance

Historical Comparison
DLNG
NTHI

About DLNG Dynagas LNG Partners LP

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and is winterized, which enables trade in subzero and ice bound conditions.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: